William D. Clark - 31 Dec 2021 Form 5 Insider Report for GENOCEA BIOSCIENCES, INC.

Role
President and CEO, Director
Signature
/s/ DIANTHA DUVALL, ATTORNEY-IN-FACT FOR WILLIAM CLARK
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
-$14,920
Form type
5
Filing time
16 Mar 2022, 17:28:03 UTC
Previous filing
13 Dec 2021
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale $10,282 -3,794 -1.3% $2.71 288,083 02 Apr 2021 Direct F1
transaction GNCA Common Stock Sale $4,638 -2,080 -0.72% $2.23 286,003 01 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.